U.S. markets close in 1 hour 26 minutes

Dicerna Pharmaceuticals: 4Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Dicerna Pharmaceuticals Inc. (DRNA) on Thursday reported a loss of $39.7 million in its fourth quarter.

The Cambridge, Massachusetts-based company said it had a loss of 58 cents per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.

The biopharmaceutical company posted revenue of $7.1 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $26.4 million.

For the year, the company reported that its loss widened to $120.5 million, or $1.76 per share. Revenue was reported as $23.9 million.

Dicerna Pharmaceuticals shares have declined 12% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $19.41, an increase of 61% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DRNA at https://www.zacks.com/ap/DRNA